Transcriptome Sequencing Identifies New Drug Targets in Prostate Cancer, Gastric Cancer, and Melanoma
June 08, 2010
Transcriptome Sequencing Identifies New Drug Targets in Prostate Cancer, Gastric Cancer, and Melanoma
A University of Michigan team identified gene fusions in the RAF kinase pathway in prostate cancer, gastric cancer, and melanoma. The researchers said the pathway could potentially be targeted by drugs that are currently in development.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Exome Sequencing of Metastatic Melanoma IDs Mutations in Pathway with Clinical Significance
April 19, 2011 / Clinical Sequencing News - Transcriptome Sequencing of 25 Prostate Cancer Tumors IDs Novel Gene Fusions
November 2, 2010 / In Sequence - Q&A: Pfizer's Mao Mao on Using Next-Generation Sequencing in Drug Development
September 7, 2010 / In Sequence - Sequencing Whole Prostate Cancer Genomes IDs Rearrangements that May Predict Disease Outcome
February 15, 2011 / In Sequence - Combination of Sequencing Techniques IDs Potential Tumor Suppressor Genes
December 7, 2010 / In Sequence